F2 Bioscience I 2017 Ltd

Insider Reports History

Location
Geneva, Switzerland
Signature
/s/ Rachel Higham /s/ Ivan Bedford, for F2 Bioscience I 2017 Limited
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by F2 Bioscience I 2017 Ltd:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Oncology, Inc. 10%+ Owner Common Stock 1,305,873 $16,271,178 $12.46 21 Jun 2022 F2 Vision SCS
Cullinan Oncology, Inc. 10%+ Owner Common Stock 1,136,525 $14,161,102 $12.46 21 Jun 2022 By Globeways Holdings Ltd.
Cullinan Oncology, Inc. 10%+ Owner Common Stock 622,175 $7,752,301 $12.46 21 Jun 2022 By F2-TPO Investments, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 537,392 $6,695,904 $12.46 23 Jun 2022 Direct
Cullinan Oncology, Inc. 10%+ Owner Common Stock 325,333 $4,053,649 $12.46 21 Jun 2022 By F2 MG Ltd.
Cullinan Oncology, Inc. 10%+ Owner Common Stock 214,798 $2,676,383 $12.46 21 Jun 2022 By F2 MC, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 112,507 $1,401,837 $12.46 21 Jun 2022 By Morana Jovan-Embiricos
Cullinan Oncology, Inc. 10%+ Owner Common Stock 104,762 $1,305,335 $12.46 21 Jun 2022 By F2 GC, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 71,599 $892,124 $12.46 21 Jun 2022 By F2 Bio TD, LLC

Insider Reports Filed by F2 Bioscience I 2017 Ltd

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CGEM Cullinan Oncology, Inc. 21 Jun 2022 3 -$1,304,816 4 10%+ Owner 23 Jun 2022, 18:47